Chemoinformaics analysis of Raceanisodamine
| Molecular Weight | 305.374 | nRot | 4 |
| Heavy Atom Molecular Weight | 282.19 | nRig | 16 |
| Exact Molecular Weight | 305.163 | nRing | 3 |
| Solubility: LogS | -1.396 | nHRing | 2 |
| Solubility: LogP | 1.053 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 45 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 1 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 23 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 5 | APOL | 48.0342 |
| nHD | 2 | BPOL | 27.3878 |
| QED | 0.809 |
| Synth | 4.467 |
| Natural Product Likeliness | 1.624 |
| NR-PPAR-gamma | 0.007 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.006 |
| Pgp-sub | 0.768 |
| HIA | 0.062 |
| CACO-2 | -5.424 |
| MDCK | 0.000198796 |
| BBB | 0.175 |
| PPB | 0.350756 |
| VDSS | 2.17 |
| FU | 0.676694 |
| CYP1A2-inh | 0.024 |
| CYP1A2-sub | 0.076 |
| CYP2c19-inh | 0.018 |
| CYP2c19-sub | 0.845 |
| CYP2c9-inh | 0.004 |
| CYP2c9-sub | 0.266 |
| CYP2d6-inh | 0.206 |
| CYP2d6-sub | 0.683 |
| CYP3a4-inh | 0.085 |
| CYP3a4-sub | 0.531 |
| CL | 6.336 |
| T12 | 0.298 |
| hERG | 0.117 |
| Ames | 0.076 |
| ROA | 0.032 |
| SkinSen | 0.672 |
| Carcinogencity | 0.199 |
| EI | 0.022 |
| Respiratory | 0.902 |
| NR-Aromatase | 0.002 |
| Antiviral | Yes |
| Prediction | 0.805406 |